Retrospective Cohort Study Comparing Infliximab|dyyb ...

Retrospective Cohort Study Comparing Infliximab-dyyb and ... - NCBI

The PROSIT-BIO observational study of a mix of biologic-naive and non-naive patients with IBD from Italy reported that infliximab-dyyb was ...

Retrospective Cohort Study Comparing Infliximab-dyyb ... - PubMed

Results: The composite effectiveness outcome occurred in 107 of 870 patients (12.3%) in the infliximab-dyyb and 379 of 2336 patients (16.2%) in ...

Retrospective Cohort Study Comparing Infliximab-dyyb and ...

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States · PDF.

Persistence of subcutaneous versus intravenous infliximab in a real ...

Discussion. In this real-life retrospective cohort study, we compared IBD patients in remission switched to subcutaneous infliximab with ...

(PDF) Retrospective Cohort Study Comparing Infliximab-dyyb and ...

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United ...

P58 A retrospective cohort study to compare subcutaneous ... - Gut

Introduction Phase III clinical trials have established the efficacy and safety of subcutaneous (SC) infliximab (IFX) in inflammatory bowel disease (IBD).

[PDF] Retrospective Cohort Study Comparing Infliximab-dyyb and ...

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States · 2 Citations.

A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort ...

This study evaluated the outcomes of patients with IBD who switched from RP infliximab to the biosimilar, infliximab-dyyb. Comparing patients in ...

Retrospective Cohort Study Comparing Infliximab-dyyb ... - EBSCO

Title. Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States.

Comparative effectiveness and drug survival of biosimilar infliximab ...

reference infliximab in inflammatory bowel disease: A retrospective cohort studyComparación de efectividad y persistencia del infliximab biosimilar CPT-13 ...

A RETROSPECTIVE COHORT STUDY TO COMPARE THE ...

A RETROSPECTIVE COHORT STUDY TO COMPARE THE EFFICACY, PHARMACOKINETICS AND SAFETY OF SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) INFLIXIMAB IN THE TREATMENT OF ...

Does long-term efficacy differ between infliximab and adalimumab ...

A STROBE-compliant retrospective cohort study ... In a retrospective study comparing the efficacies ... compared to infliximab: a real life cohort study.

A 'real‐world' retrospective multi‐centre cohort study comparing ...

Patients with UC administered infliximab or adalimumab as their first biologic, identified from the therapy databases of five UK hospitals, were ...

P58 A retrospective cohort study to compare subcutaneous with ...

Introduction Phase III clinical trials have established the efficacy and safety of subcutaneous (SC) infliximab (IFX) in inflammatory bowel ...

Long-term effectiveness and safety of infliximab-biosimilar - PLOS

Research Article. Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study. Tomoe Kazama ...

P782 Comparison of accelerated and standard infliximab induction ...

... retrospective multicenter study in a Chinese cohort. X Liu ,. X Liu. Peking Union Medical College Hospital- Peking Union Medical College ...

Vedolizumab is superior to infliximab in biologic naïve patients with ...

... anti-TNF ... First, despite the absence of prospective randomized trial comparing ... In the retrospective multicenter European pooled cohort study ...

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is ...

Infliximab is a safe and effective therapy for ulcerative colitis (UC). We conducted a multicenter retrospective cohort study that included 7 European ...

P100 REAL-WORLD COMPARISON OF ARTHRALGIAS WITH ...

We performed a retrospective cohort study of bio-naïve adult patients treated with IFX or VDZ for ulcerative colitis (UC) or Crohn's disease (CD) at a large ...

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is ...

We performed a retrospective cohort study ... No prospective studies are available comparing alternative regimens. ... infliximab, compared ...